Taysha Gene Therapies (TSHA) PT Raised to $36 at Goldman Sachs

March 4, 2021 1:02 AM EST
Get Alerts TSHA Hot Sheet
Price: $16.18 +1.44%

Rating Summary:
    10 Buy, 1 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 10 | Down: 8 | New: 36
Trade Now! 
Join SI Premium – FREE
Goldman Sachs analyst Salveen Richter raised the price target on Taysha Gene Therapies (NASDAQ: TSHA) to $36.00 (from $34.00) while maintaining a Buy rating.

You May Also Be Interested In

Related Categories

Analyst PT Change